Greenfern Industries Limited (GFI) Releases Interim Results

Medicinal cannabis and hemp company Greenfern Industries Ltd (GFI) has today released its interim results to 30 September2021. GFI chairman Brent King said the accounts weren't particularly relevant as Greenfern was listed on the NZX on October 21 and there were a number of transactions just before the listing. "The accounts and the report are compiled to meet our listing requirements and we are happy to provide them to our shareholders and to the market. "There has been significant progress made and the business is developing very well since our listing date. We have been very pleased to see an increase in shareholder numbers from approximately 1900 to over 3000, a significant portion of which has been through Sharesies." Managing director Dan Casey was pleased to see strong support from retail customers. "The crowdfunding investor understands the cannabis and hemp market better than many of the more conservative investors. Our aspirational growth plans appeal to this market as many have watched the rapid growth of similar companies in the USA, Canada and Australia." Casey said GFI had several approaches since the share market listing and the company was exploring those opportunities. "We're working hard to create long-term value for our shareholders and we'll update the market in due course." Greenfern has recently planted its hemp crops in Normanby, Taranaki and Lake Hawea, Central Otago. It has also commenced selling its GFI Pharma-branded medicinal cannabis products in Australia and will have four separate SKUs available in the Australian market in the near term with a view to also enter the NZ market once regulatory approvals have been granted. For further information, please contact: Dan Casey Managing Director, Greenfern Industries Ph: 0274 202 476 Email: dan@gfi.nz End CA:00383684 For:GFI Type:HALFYR Time:2021-11-26 14:01:10